Following GAP's Partnering model usually involvesletters of intent from various suitors which legally demand confidentiality agreements, so they probably can't even state that they are in talks with a Big Pharma. We know that research results are imminent, but remember they stated “Results are anticipated during the first half of 2010.” That leaves 2 more months. If the executive team decides to publish all results in one NR, they will have blatantly missed PR opportunities. Let's hope they don't. Yes, we know they won't "pump", yet they tease us with "ongoing research". Beware the M&A ego. Unless they hit one out of the park (sign a partner with upfront and milestone payments), IMHO, we won't hear from them. So, if there is nothing but SEDAR reports until the AGM (June 24), my spidey senses will tell me to bail.
Caveat emptor.
CJ